{"url":"https://lda.senate.gov/api/v1/filings/e7da9a39-e368-4e17-8d77-ba84853b14b2/","filing_uuid":"e7da9a39-e368-4e17-8d77-ba84853b14b2","filing_type":"Q3","filing_type_display":"3rd Quarter - Report","filing_year":2024,"filing_period":"third_quarter","filing_period_display":"3rd Quarter (July 1 - Sep 30)","filing_document_url":"https://lda.senate.gov/filings/public/filing/e7da9a39-e368-4e17-8d77-ba84853b14b2/print/","filing_document_content_type":"text/html","income":null,"expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Dave Smolensky","dt_posted":"2024-10-14T14:53:18-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"27 N Wacker","registrant_address_2":"Ste 403","registrant_different_address":false,"registrant_city":"Chicago","registrant_state":"IL","registrant_zip":"60606","registrant":{"id":401106654,"url":"https://lda.senate.gov/api/v1/registrants/401106654/","house_registrant_id":45630,"name":"RESOLUTE-DC","description":null,"address_1":"27 N Wacker","address_2":"Ste 403","address_3":null,"address_4":null,"city":"Chicago","state":"IL","state_display":"Illinois","zip":"60606","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"DAVE SMOLENSKY","contact_telephone":"+1 312-673-3538","dt_updated":"2025-07-09T14:45:56.177127-04:00"},"client":{"id":57734,"url":"https://lda.senate.gov/api/v1/clients/57734/","client_id":57734,"name":"MODEL MEDICINES","general_description":"US-based, artificial intelligence-driven drug discovery and development company","client_government_entity":null,"client_self_select":false,"state":"CA","state_display":"California","country":"US","country_display":"United States of America","ppb_state":"CA","ppb_state_display":"California","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2023-10-15"},"lobbying_activities":[{"general_issue_code":"MED","general_issue_code_display":"Medical/Disease Research/Clinical Labs","description":"Introduce Model Medicines and how the company is innovating at the intersection of data science, biology and drug development.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":144036,"prefix":null,"prefix_display":null,"first_name":"GREG","nickname":null,"middle_name":null,"last_name":"GOLDNER","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":34,"name":"Health & Human Services, Dept of (HHS)"}]},{"general_issue_code":"PHA","general_issue_code_display":"Pharmacy","description":"Introduce Model Medicines and how the company is innovating at the intersection of data science, biology and drug development.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":144036,"prefix":null,"prefix_display":null,"first_name":"GREG","nickname":null,"middle_name":null,"last_name":"GOLDNER","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":34,"name":"Health & Human Services, Dept of (HHS)"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}